Percutek Therapeutics

Medical Devices & EquipmentSeries FBeijing, Chinahuamaitaike.com

Latest round

Series F

Last raised

Dec 2021

Total raised

Undisclosed

Investors

19

About Percutek Therapeutics

, trading under the name Percutek Therapeutics, focuses on the innovation and clinical application of medical devices for vascular disease treatment. The company has developed a portfolio of interventional devices used across multiple areas including aortic, peripheral, and neurovascular intervention. Over the years, Percutek Therapeutics has expanded its R&D and manufacturing capabilities to enhance product quality and meet clinical demand in China’s cardiovascular healthcare sector. The company provides a range of medical devices for vascular intervention, including the PERCUTEK AAA Stent-Graft for abdominal aortic aneurysm repair, the PERCUTEK TBAD Stent-Graft for thoracic aortic dissection, the Huamai Vein Stripping Guidewire for venous intervention, as well as hydrophilic guidewires and vascular closure sets for minimally invasive vascular procedures. The company generates revenue through the sale of its medical devices and interventional systems to hospitals, clinics and distributors in China. Income is primarily derived from sales of stent-graft systems, guidewires and vascular closure devices.

Who invested in Percutek Therapeutics

19 investors across 8 rounds

See all investors in Percutek Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series F

    Dec 22, 2021

    Amount

    Undisclosed

    Investors

    Locked

  2. Series E

    Aug 1, 2020

    Amount

    Undisclosed

    Investors

    Locked

  3. Series D

    Jun 21, 2019

    Amount

    Undisclosed

    Investors

    Locked

  4. Series C

    Dec 1, 2017

    Amount

    Undisclosed

    Investors

    Locked

  5. Series C

    Jun 1, 2017

    Amount

    Undisclosed

    Investors

    Locked

  6. Series B

    Jan 12, 2017

    Amount

    Undisclosed

    Investors

    Locked

  7. Series A

    Apr 1, 2015

    Amount

    Undisclosed

    Investors

    Locked

  8. Angel

    Feb 1, 2014

    Amount

    Undisclosed

    Investors

    Locked

Questions about Percutek Therapeutics

Who invested in Percutek Therapeutics?

Percutek Therapeutics has 19 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Percutek Therapeutics raised?

Percutek Therapeutics has raised 8 venture rounds. Sign up free to see how much each round raised and the total.

When did Percutek Therapeutics last raise money?

Percutek Therapeutics's most recent round on record is a Series F, in Dec 2021.

What does Percutek Therapeutics do?

, trading under the name Percutek Therapeutics, focuses on the innovation and clinical application of medical devices for vascular disease treatment.

Where is Percutek Therapeutics headquartered?

Percutek Therapeutics is headquartered in Beijing, China.

Which VCs invest in companies like Percutek Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Percutek Therapeutics's stage. Their profiles are linked below.

Raising like Percutek Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.